Dundee, United Kingdom

Janice McLachlan



Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Janice McLachlan: Innovator in Pharmaceutical Compounds

Introduction

Janice McLachlan is a notable inventor based in Dundee, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating various medical disorders. With a total of 2 patents to her name, her work has the potential to impact the healthcare industry positively.

Latest Patents

Janice's latest patents include the development of Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds. This invention relates to compounds of a specific formula, which can be used in pharmaceutical compositions for treating a variety of disorders, including proliferative disorders, viral disorders, and strokes. Another significant patent involves Pyrimidin-4-yl-3, 4-thione compounds, which also have therapeutic applications for conditions such as alopecia and diabetes.

Career Highlights

Janice McLachlan is currently associated with Cyclacel Limited, where she continues to advance her research and development efforts. Her work focuses on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Janice collaborates with esteemed colleagues, including Kenneth Duncan and Daniella I Zheleva, to enhance the scope and impact of her research. Their combined expertise contributes to the innovative environment at Cyclacel Limited.

Conclusion

Janice McLachlan's contributions to pharmaceutical innovations demonstrate her commitment to improving healthcare through her inventive work. Her patents reflect a dedication to addressing significant medical challenges, making her a valuable figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…